Re-Defining Primary Aldosteronism
authors.elsevier.com/a/1mqFw2d9GI...
@jaccjournals.bsky.social #JACC
In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ACC26, such as STEMI-DTU, ORBITA-CTO, & more!
📽️: youtu.be/xvLFmv2-Et0?...
#JACC #CardioSky @accintouch.bsky.social
#ACC26 DKCRUSH VIII: When using the two-stent DK crush technique for #PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated w/ a greater reduction in target vessel failure compared to angiography-guided PCI.
More: 🔗 https://bit.ly/47w3WRR #CardioSky #JACC
#ACC26 CORALreef AddOn: The novel PCSK9 oral inhibitor enlicitide effectively lowered LDL-C in adults already being treated with statins, demonstrating a potential role as an add-on option for patients not meeting LDL-C goals.
Learn more: https://bit.ly/4uW7VRL #JACC #CardioSky
FUND-HF pilot shows feasible early post-discharge financial support in low-income HF patients, improving medication adherence. Findings inform larger trials to assess durability and effects on HRQOL and outcomes. https://bit.ly/4sC2NR7
#JACC #SDOH #QoL #ACC26 #CardioSky
Oral #enlicitide lowered LDL-C, #ApoB, & non-HDL-C more than oral non-statin comparators at day 56 in statin-treated adults with a history of a major #ASCVD event or at increased risk for a first event. https://bit.ly/47Ao7hw
#ACC26 #JACC #PCSK9i #CardioSky
In this RCT of complex bifurcation #PCI using DK crush technique, 1-year benefits of #IVUS-guided PCI were driven by achieving IVUS optimization targets, not IVUS use alone. https://bit.ly/4s1UWek
#JACC #ACC26 #CardioSky
Electronic clinician notification alerts were shown to be effective in improving the timely evaluation & treatment of pts w/ severe #vhdAS or #vhdMR, according to the ALERT trial presented during a Featured Clinical Research session at #ACC26.
More: https://bit.ly/3NTwMVA #JACC #CardioSky
Cluster randomized trial: Automated ECN alerts improved timely guideline-directed evaluation & valve intervention for sig. AS & MR, supporting scalable EHR-based decision support to reduce undertreatment & improve access to valve care https://bit.ly/4ccYEND
#JACC #ACC26 #vhdAS #vhdMR #CardioSky
In patients with symptomatic single-vessel coronary chronic total occlusion (CTO), #PCI for CTO improved angina beyond placebo, according to findings from the ORBITA-CTO trial presented at #ACC26 and simultaneously published in #JACC.
Learn more: https://bit.ly/4uSdZKR #CardioSky
In patients with symptomatic single-vessel chronic total occlusion, percutaneous coronary intervention for coronary chronic total occlusion (CTO PCI) improves angina beyond placebo.
Get the details in #JACC: https://bit.ly/4tfFPza #ACC26 #PCI #CTO #CardioSky
Late-breaking KARDINAL trial explores efficacy of tonlamarsen in patients with uncontrolled hypertension. Read more in #JACC: bit.ly/4uT83l3
#ACC26 #Hypertension #CardioSky
Combination of a TV-mAFP plus delayed #PCI did not reduce infarct size in patients with anterior #STEMI without cardiogenic shock compared with PCI alone, according to an #ACC26 #JACC LBCT.
Get the details: https://bit.ly/4bEo9aD #CardioSky
New 2026 ACC scientific statement reviews gene editing therapy in #CVD, covering the science, early targets (monogenic diseases), and key ethical and cost challenges. Clinicians play a critical role in guiding safe, equitable use. https://bit.ly/4rYSW6W
#JACC #CRISPR #cvGenetics #CardioSky
Outpatient management of isolated left-to-right shunt lesions in pediatric #CHD is the focus of a new 2026 ACC Concise Clinical Guidance report in #JACC, offering a decision support framework in the current absence of evidence-based clinical guidelines. https://bit.ly/4lRUFcL #cvPed #CardioSky
New multisociety consensus outlines operator & institutional requirements for tricuspid interventions & guidance for implementing & maintaining a transcatheter tricuspid valve intervention program in a rapidly evolving field.
Get the details in #JACC: https://bit.ly/4rUYP4T #vhdTR #TTVI #CardioSky
After the Inflation Reduction Act's 2024 provisions took effect, cost-related medication non-adherence fell among Medicare beneficiaries newly eligible for low-income subsidies at elevated CV risk. https://bit.ly/4bwJmDj
#ACC26 #JACC #CardioSky @rkwadhera.bsky.social
Featured on the @todayshow.com: @nbcnews.com medical reporter Dr. Akshay Syal discusses @accintouch.bsky.social and @americanheart.bsky.social's new guideline for managing #cvLipids and #Cholesterol.
📺Watch the video: on.today.com/4lFVuVY #JACC
The latest commentary by Omar Hahad et al., now published in #ScienceDirect, responds to recent findings by Xue et al. in #JACC and highlights a critical shift in how we understand hypertension-related mortality. 🫀🏥
🔗 Full editorial comment: www.sciencedirect.com/science/arti...
🆕 #JACC Leadership Page outlines the legacy of collaboration between @sts.org and ACC, and explores the ways the two societies are upholding standards while expanding horizons with #ACCPresident Dr. @chriskramermd.bsky.social & STS President Dr. Vinay Badhwar.
🔗 https://bit.ly/3PLvH2u #ACCLeadership
The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.
A quick reference for clinicians: https://bit.ly/4rGIMHY
#JACC #ClinicalGuidelines #cvLipids #CardioSky
🆕 ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management & monitoring of individuals w/ dyslipidemias.
Read the full guideline in #JACC: https://bit.ly/4cLB0J0 #cvLipids #ClinicalGuidelines #CardioSky #MedSky
ACC/AHA & 9 other leading medical associations released an updated clinical guideline for managing #dyslipidemia. About 1 in 4 US adults has high LDL-C, raising risk of heart attack & stroke.
Get the details in #JACC: https://bit.ly/4cLB0J0
#ClinicalGuidelines #cvLipids #ASCVD #CardioSky
image_0
JACC (Austràlia) presenta nou àlbum: "Eternal Empyrean of Sepulchral Nullity" #Jacc #RawBlackMetal #Març2026 #Austràlia #NouÀlbum #Metall #Metal #MúsicaMetal #MetalMusic
Sotatercept boosts exercise tolerance in PAH by raising hemoglobin (partly via decongestion), improving RV‑PA coupling and CO reserve, & increasing skeletal muscle O₂ delivery & utilization, all while reducing RV workload.
Get the details in #JACC: https://bit.ly/40JGHj7 #THT2026 #cvPAH #CardioSky
Discover #JACC’s newest Mini Spotlight Issue, highlighting the updated 2025 #ACHD Guideline with dynamic, expert driven insights into the evolving landscape of ACHD care.
Read now ➡️ https://bit.ly/4l118BO #CardioSky #MedSky @jaccjournals.bsky.social
The 2026 ACC/AHA/Multisociety #ClinicalGuideline on acute PE focuses on evaluation, management, & follow-up of adult patients.
This Guideline-at-a-Glance highlights practice-changing recommendations from the guideline to accelerate adoption. ➡️ https://bit.ly/4rwGoEd
#JACC #CardioSky #MedSky
2026 ACC/AHA/Multisociety guideline on acute pulmonary embolism highlights practice-changing recommendations for the evaluation & management of acute PE in adults.
Explore the Guideline-at-a-Glance in #JACC to accelerate adoption in practice: https://bit.ly/4rwGoEd #ClinicalGuidelines #CardioSky
🆕 ACC/AHA/Multisociety Guideline for the Evaluation & Management of Acute PE in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management & follow‑up of adults with acute PE. https://bit.ly/4aE5gmi
#JACC #CardioSky #ClinicalGuidelines
A traditional Chinese mind-body practice that combines slow, structured movement, deep breathing & meditative focus lowered BP as effectively as brisk walking, in a large RCT published in #JACC. BP reductions were seen after 3 months & sustained for 1 year. https://bit.ly/4kKQrDh #CardioSky